Cardiovascular Assessment of Ponatinib as Third Line Treatment in Chronic Phase Chronic Myeloid Leukemia
Clinical trial NCT04709731 · UNKNOWN
Trial details
- NCT number
- NCT04709731
- Sponsor
- Associazione Italiana Pazienti Leucemia Mieloide Cronica
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-01
- Primary completion
- 2024-10-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.